1000-6702
2010 Issue 1
jin run xing bang zuo niao lu shang pi ai de xin fu zhu hua liao jin zhan
zuo wei ; wang wei ; chen shan
zuo wei ; wang wei ; chen shan
..............page:67-69
..............page:17,20,23,44,62
zuo shen zuo ye yang xiao guan zhuang he suo xing xi bao ai yi li bao gao
wu jian ; zheng jing cun
wu jian ; zheng jing cun
..............page:55
Influence of overactive bladder on symptoms and quality of life in patients treated with mid-urethral suspension
WANG Biao;TANG Xing-xing;ZHANG Peng;WU Zhi-jin;ZHANG Xiao-dong;YANG Yong
WANG Biao;TANG Xing-xing;ZHANG Peng;WU Zhi-jin;ZHANG Xiao-dong;YANG Yong
..............page:56-58
Phase Ⅳ clinical trial of sorafenib in combination with interferon-alpha as the first-line treatment in patients with advanced renal cell carcinoma:interim analysis of efficacy and safety
HUANG Yi-ran;MA Jian-hui;HUANG Jian;NA Yan-qun;SUN Yan
HUANG Yi-ran;MA Jian-hui;HUANG Jian;NA Yan-qun;SUN Yan
..............page:5-7
Gene expression change study in hypospadias by microarray
MA Li-min;ZHOU Juan;WANG Zhong;JIANG Hua;LIU Ben-chun;DA Jun;Laurence S.Baskin
MA Li-min;ZHOU Juan;WANG Zhong;JIANG Hua;LIU Ben-chun;DA Jun;Laurence S.Baskin
..............page:63-66
Is it essential to excise ipsilateral adrenal in radical nephrectomy?
ZHANG Zhi-ling;LIU Zhuo-wei;LI Yong-hong;HOU Guo-liang;HAN Hui;QIN Zi-ke;ZHANG Xue-qi;ZHOU Fang-jian
ZHANG Zhi-ling;LIU Zhuo-wei;LI Yong-hong;HOU Guo-liang;HAN Hui;QIN Zi-ke;ZHANG Xue-qi;ZHOU Fang-jian
..............page:35-37
Efficacy of sorafenib in treating metastatic renal cell carcinoma with sarcomatoid feature
ZHANG Hai-liang;YE Ding-wei;YAO Xu-dong;ZHANG Shi-lin;DAI Bo;SHEN Yi-jun;ZHU Yao;ZHU Yi-ping;SHI Guo-hai;MA Chun-guang;XIAO Wen-jun;QIN Xiao-jian;LIN Guo-wen
ZHANG Hai-liang;YE Ding-wei;YAO Xu-dong;ZHANG Shi-lin;DAI Bo;SHEN Yi-jun;ZHU Yao;ZHU Yi-ping;SHI Guo-hai;MA Chun-guang;XIAO Wen-jun;QIN Xiao-jian;LIN Guo-wen
..............page:15-17
Preliminary evaluation about efficacy and safety of sorafenib therapy in elderly patients with advanced renal cell carcinoma
ZHANG Qi-fu;WANG Qing;FU Cheng;ZHOU Chang-dong;JIN Gang;TIAN Yu-xin;LIU Yi;WANG Ying-di
ZHANG Qi-fu;WANG Qing;FU Cheng;ZHOU Chang-dong;JIN Gang;TIAN Yu-xin;LIU Yi;WANG Ying-di
..............page:12-14
Laparoscopic nephron sparing surgery in the treatment of renal tumors
YANG Dian-dong;GAO Zhen-li;LIN Chun-hua;MEN Chang-ping;CHEN Bo;WANG Hui;WU Ji-tao
YANG Dian-dong;GAO Zhen-li;LIN Chun-hua;MEN Chang-ping;CHEN Bo;WANG Hui;WU Ji-tao
..............page:32-34
Application of 3-dimensional CT reconstruction in the diagnosis of posterior urethral strictures or ankylurethria
XUE Ya-gang;SA Ying-long;SONG Lu-jie;SI Jie-min;XU Yue-min
XUE Ya-gang;SA Ying-long;SONG Lu-jie;SI Jie-min;XU Yue-min
..............page:59-62
Clinical study of sorafenib for patients with advanced renal cell carcinoma
ZHAO Xin;SHOU Jian-zhong;ZHOU Ai-ping;DU Chun-xia;SUN Yong-kun;WANG Jin-wan;MA Jian-hui
ZHAO Xin;SHOU Jian-zhong;ZHOU Ai-ping;DU Chun-xia;SUN Yong-kun;WANG Jin-wan;MA Jian-hui
..............page:8-11
Efficacy of sorafenib in treating metastatic non-clear cell renal cell carcinoma
ZHANG Hai-liang;YE Ding-wei;YAO Xu-dong;ZHANG Shi-lin;DAI Bo;SHEN Yi-jun;ZHU Yao;ZHU Yi-ping;SHI Guohai;MA Chun-guang;XIAO Wen-jun;QIN Xiao-jian;LIN Guo-wen
ZHANG Hai-liang;YE Ding-wei;YAO Xu-dong;ZHANG Shi-lin;DAI Bo;SHEN Yi-jun;ZHU Yao;ZHU Yi-ping;SHI Guohai;MA Chun-guang;XIAO Wen-jun;QIN Xiao-jian;LIN Guo-wen
..............page:18-20
Effect of peroxisome proliferator-activated receptor γ agonist on prostate epithelial cells
ZHENG Lan-bin;ZHAO Ya-yuan;YU Wei;GUO Hui;JIN Jie
ZHENG Lan-bin;ZHAO Ya-yuan;YU Wei;GUO Hui;JIN Jie
..............page:52-55
Analysis of subclinical Cushing syndrome
ZHANG Rui-qiang;ZHANG Yu-shi;WANG Hai;LI Han-zhong
ZHANG Rui-qiang;ZHANG Yu-shi;WANG Hai;LI Han-zhong
..............page:42-44
zuo shen hun he xing shang pi jian zhi zhong liu yi li bao gao
lang lang ; song bo ; zhang rong
lang lang ; song bo ; zhang rong
..............page:27
Efficacy and safety of diffirent hormonal therapy regiments in advanced prostate cancer patients
HUANG Hai;XU Ke-wei;HUANG Jian;DONG Wen;JIANG Chun;LIN Tian-xin;GUO Zheng-hui;YAO You-sheng;XIE Wen-lian;HAN Jin-li
HUANG Hai;XU Ke-wei;HUANG Jian;DONG Wen;JIANG Chun;LIN Tian-xin;GUO Zheng-hui;YAO You-sheng;XIE Wen-lian;HAN Jin-li
..............page:45-48
Laparoscopic partial nephrectomy with hypothermic renal artery perfusion in situ
LI Han-zhong;DONG De-xin;YAN Wei-gang;ZHANG Yu-shi
LI Han-zhong;DONG De-xin;YAN Wei-gang;ZHANG Yu-shi
..............page:28-31
Impacts of detrusor overactivity on patients with benign prostate hyperplasia
ZHANG Peng;WU Zhi-jin;YANG Yong;ZHANG Xiao-dong
ZHANG Peng;WU Zhi-jin;YANG Yong;ZHANG Xiao-dong
..............page:49-51
Diagnosis and treatment of pneumocystis carinii pneumonitis after renal transplantation
PEI Guang-hui;SONG Wen-li;MO Chun-bai;WANG Zhi-ping
PEI Guang-hui;SONG Wen-li;MO Chun-bai;WANG Zhi-ping
..............page:38-41
Clinical evaluation of dose escalation of sorafenib in treating advanced renal cell carcinoma after failing to rutine dosage of sorafenib
ZHANG Hai-liang;YE Ding-wei;YAO Xu-dong;ZHANG Shi-lin;DAI Bo;SHEN Yi-jun;ZHU Yao;ZHU Yi-ping;SHI Guo-hai;MA Chun-guang;XIAO Wen-jun;QIN Xiao-jian;LIN Guo-wen
ZHANG Hai-liang;YE Ding-wei;YAO Xu-dong;ZHANG Shi-lin;DAI Bo;SHEN Yi-jun;ZHU Yao;ZHU Yi-ping;SHI Guo-hai;MA Chun-guang;XIAO Wen-jun;QIN Xiao-jian;LIN Guo-wen
..............page:24-27
Sorafenib in the treatment of advanced renal clear cell carcinoma
ZHANG Gang;WANG Yong-gang;WANG Zhi-xin;KONG Xiang-bo;LI Yu-feng;WANG Kai-chen
ZHANG Gang;WANG Yong-gang;WANG Zhi-xin;KONG Xiang-bo;LI Yu-feng;WANG Kai-chen
..............page:21-23
..............page:71-72
..............page:41,48,69,70